SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company's total revenue for the quarter ended September 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 605.26 millions.Net profit for the quarter ended September 2022 increased significantly by 58.61% to Rs. 104.11 millions from Rs. 65.64 millions.OP of the company witnessed a marginal growth to 140.22 millions from 96.87 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 605.26 583.93 3.65 1211.23 1124.48 7.71 2260.97 1879.46 20.30
Other Income 11.21 2.85 293.33 14.34 11.07 29.54 33.36 43.93 -24.06
PBIDT 140.22 96.87 44.75 207.53 197.84 4.90 291.31 234.72 24.11
Interest 0.26 0.63 -58.73 0.40 1.68 -76.19 2.85 5.14 -44.55
PBDT 139.96 96.24 45.43 149.09 196.16 -24.00 288.46 229.58 25.65
Depreciation 2.04 2.28 -10.53 3.97 5.11 -22.31 15.26 10.86 40.52
PBT 137.92 93.96 46.79 145.12 191.05 -24.04 273.20 218.72 24.91
TAX 33.81 28.32 19.39 37.32 56.91 -34.42 77.32 48.14 60.61
Deferred Tax 1.43 -1.24 -215.32 -3.25 -1.11 192.79 0.00 0.00 0.00
PAT 104.11 65.64 58.61 107.80 134.14 -19.64 195.88 170.58 14.83
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 23.17 16.59 39.65 17.13 17.59 -2.62 12.88 12.49 3.17

Jagsonpal Pharma Share Price

192.80 -0.85 (-0.44%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×